ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

Loeb Named ACS President, Eyre President Elect

November 14, 1986

President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89

January 13, 1989

Beahrs Report Urges Mammography Continuation, Says BCDDPs Effective In Detecting Early Cancer

September 17, 1977

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

July 8, 1988

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008